Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avricore Health (AVCRF) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for Avricore Health (AVCRF) over the last 17 years, with Q3 2025 value amounting to -$274778.7.

  • Avricore Health's Income from Continuing Operations fell 11421.22% to -$274778.7 in Q3 2025 from the same period last year, while for Sep 2025 it was -$600189.0, marking a year-over-year decrease of 84924.55%. This contributed to the annual value of $94222.3 for FY2024, which is 11833.78% up from last year.
  • According to the latest figures from Q3 2025, Avricore Health's Income from Continuing Operations is -$274778.7, which was down 11421.22% from -$339282.8 recorded in Q2 2025.
  • In the past 5 years, Avricore Health's Income from Continuing Operations ranged from a high of $117616.8 in Q1 2024 and a low of -$339282.8 during Q2 2025
  • For the 5-year period, Avricore Health's Income from Continuing Operations averaged around -$99402.8, with its median value being -$128274.1 (2024).
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first tumbled by 176833.34% in 2021, then soared by 18226.55% in 2024.
  • Over the past 5 years, Avricore Health's Income from Continuing Operations (Quarter) stood at -$105615.3 in 2021, then tumbled by 64.91% to -$174171.3 in 2022, then surged by 129.34% to $51100.9 in 2023, then rose by 29.56% to $66206.0 in 2024, then plummeted by 515.04% to -$274778.7 in 2025.
  • Its last three reported values are -$274778.7 in Q3 2025, -$339282.8 for Q2 2025, and -$52333.5 during Q1 2025.